JRGD:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (dist) (EUR)

ETF | Others |

Last Closing

USD 43.815

Change

+0.10 (+0.23)%

Market Cap

USD 2.00M

Volume

1.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.30 (+0.57%)

USD 511.43B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.07 (+0.42%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.16 (+0.55%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.48%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.56%)

USD 100.46B
8R80:XETRA Amundi Index Solutions - Amund..

+0.46 (+0.32%)

USD 98.85B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.23 (+0.45%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.58 (-0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.20 (+0.88%)

USD 79.79B

ETFs Containing JRGD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.25% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.25% 83% B 81% B-
Trailing 12 Months  
Capital Gain 25.67% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.67% 83% B 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.74% 61% D- 60% D-
Dividend Return 6.74% 60% D- 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.64% 60% D- 69% C-
Risk Adjusted Return 69.89% 77% C+ 79% B-
Market Capitalization 2.00M 2% F 1% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.